SHAREHOLDER UPDATES

Q2 2008 Shareholder Presentation

Investor Fact Sheet

Investor Conference and Annual Meeting – New York, NY – May 19th

2007 Annual Report

AMERICAN CAPITAL NEWS

American Capital Realizes $57 Million Gain from Sale of Contec, Provides Financing to Support Acquisition by Bain Capital with Contec Management

American Capital Declares $1.05 Q3 2008 Dividend, Reports $0.71 NOI and $0.95 Realized Earnings in Q2 2008

More American Capital News »

PRESS COVERAGE

Buyouts Beat: Five Questions with Bowen Diehl, Buyouts

American Capital Portfolio Company Confluence's new CEO aims to boost sales, The Greenville News

More Press Coverage »

STOCK RETURNS CALCULATOR

Calculate Returns On Your
American Capital Stock

* Includes Dividends Reinvested

OUR PORTFOLIO

American Capital Portfolio Companies

The Redwood Companies

American Capital exited its investment in The Redwood Companies in the fourth quarter of 2007.

Visit Redwood Companies websites:
www.redwoodtoxicology.com
www.redwoodbiotech.com
www.permaxim.com

American Capital Provides Details of $41 Million Net Realized Gains from Portfolio Companies in Fourth Quarter 2007
Bethesda, MD – February 14, 2008 – American Capital Strategies Ltd. (Nasdaq: ACAS) announced today information regarding $41 million of total net realized gains from the disposition of portfolio investments in the fourth quarter of 2007. The portfolio net realized gains exclude realized gains or losses from interest rate derivatives, taxes on realized gains and foreign currency transactions. During the fourth quarter of 2007, American Capital received $1.5 billion of proceeds from the disposition of portfolio investments.[more...]

American Capital Invests $79.5 Million In One Stop Buyout™ of The Redwood Companies
Bethesda, MD - March 21, 2006 - American Capital Strategies Ltd. (Nasdaq:ACAS) announced today it has invested $79.5 million in the One Stop Buyout™ of Redwood Toxicology Laboratory Inc., Redwood Biotech Inc. and PerMaxim LLC (collectively, "The Redwood Companies" or "Redwood"). Redwood is a leading provider of drugs-of-abuse lab testing services and on-site test kits to the correctional, rehabilitation and point-of-care markets. American Capital's investment took the form of a revolving credit facility, senior term debt, senior subordinated debt and preferred and common equity. Post close, American Capital owns 67% of the Company, on a fully diluted basis, with members of Redwood's management team owning the remaining balance. [more...]